ClinicalTrials.gg
Sign In
Drug

Atazanavir/Cobicistat clinical trials

studies test it
5
open now
0
in phase 3
1
first study started
2015

How each study uses Atazanavir/Cobicistat is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study

Approvals

The first approval found in each region, with its record

United States
29 Jan 2015 · EVOTAZ · NDA 206353 (FDA, Drugs@FDA)
European Union
13 Jul 2015 · Evotaz · EMEA/H/C/003904 (EMA)

From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out

How studies write it

Studies that test it under each name

Name

Evotaz
4
Atazanavir/Cobicistat
1

Studies by the year they started

5 studies that test it; most in 2015 (2)

Studies that test Atazanavir/Cobicistat, by start year
YearStudies
20152
20161
20201
20221

By phase

A phase 1/2 study counts in both.

Phase 1
4
Phase 3
1

Who runs them

Industry 3 · Other 2

Bristol-Myers Squibb (2) · St Stephens Aids Trust (2) · Gilead Sciences (1)

Often tested with

Tested in the same studies.

Cobicistat (3) · Atazanavir (2) · Cobicistat mixture with darunavir (2) · Ritonavir (1) · Darunavir (1) · Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination (1) · Abacavir, lamivudine drug combination (1) · Ethinyl Estradiol (1)

Related medicines

As reviewed, each with the page that says it.

Studies

Open first, then newest update. How each study uses Atazanavir/Cobicistat is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.

Testing it · 5